Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New rehab program shows promise for long COVID sufferers

NCT ID NCT06156202

Symptom relief Sponsor: University of Pennsylvania Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a 6-week outpatient rehab program for 125 adults with Long COVID. The program included physical and speech therapy tailored to each person's needs, aiming to improve breathing, thinking, and daily function. Researchers measured progress using a six-minute walk test and other assessments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
comprehensive rehabilitation program (speech therapy and physical therapy)
What this could lead to
If it works, this could point toward an effective rehab program to help people with Long COVID feel better and function more normally.
What could go wrong
This is a small, completed study without a control group for comparison, so results may not apply to everyone. Benefits may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

125 people

The number who actually took part.

Started

Nov 2023

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years if age or older * English or Spanish speaking * Previously tested positive for COVID * Still having symptoms not explained by any other etiologies * Cognitive impairment * Fatigue Exclusion Criteria: * Participation in another clinical trial * Score greater than 12 on the fatigue scale * Score greater than 30 on the memory/thinking scale * Severe cognitive impairment (i.e. Alzheimer's, Dementia) * Mental or physical inability to participate in the program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive impairment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction Dizziness Dyspnea long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive impairment Dyspnea Long COVID Long COVID19 Orthostasis Post-acute COVID-19 Post-acute COVID-19 infection Post-acute COVID-19 syndrome

Contacts and locations

Locations

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19145, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.